Fever and Brugada syndrome

PACE - Pacing and Clinical Electrophysiology

Volumn 25, Issue 11, 2002, Pages 1537-1539

  Antzelevitch, Charles ^a   Brugada, Ramon ^a  

^a MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AJMALINE; ANTIARRHYTHMIC AGENT; DISOPYRAMIDE; FLECAINIDE; PILSICAINIDE; PINACIDIL; PROCAINAMIDE; PROPAFENONE; QUINIDINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; VERAPAMIL;

AUTOSOMAL DOMINANT DISORDER; BRUGADA SYNDROME; CLINICAL FEATURE; DRUG MECHANISM; EDITORIAL; ELECTROCARDIOGRAM; FEVER; GENE LOCUS; HEART ARRHYTHMIA; HUMAN; LONG QT SYNDROME; MISSENSE MUTATION; PATHOGENESIS; PROGNOSIS; SLEEP; SODIUM CURRENT; ST SEGMENT ELEVATION; SUDDEN DEATH; ELECTROCARDIOGRAPHY; GENETICS; HEART BUNDLE BRANCH BLOCK; METABOLISM; PATHOPHYSIOLOGY; SYNDROME;

BUNDLE-BRANCH BLOCK; DEATH, SUDDEN; ELECTROCARDIOGRAPHY; FEVER; HUMANS; SYNDROME;

EID: 1842841853     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.2002.01537.x     Document Type: Editorial

References (39)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome: A multicenter report. J Am Coll Cardiol 1992; 20:1391-1396.
2. Yan GX, Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 1996; 93:372-379.
3. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-1070.
4. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanisms for idiopathic ventricular fibrillation. Nature 1998; 392:293-296.
5. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999; 85:803-809.
6. Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: Physiological, pharmacological and clinical implications. In HA Fozzard, RJ Solaro (eds.): Handbook of Physiology. The Heart. NY, Oxford University Press, 2002.
7. Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001; 12:268-272.
8. Balser JR. The cardiac sodium channel: Gating function and molecular pharmacology. J Mol Cell Cardiol 2001; 33:599-613.
9. Bezzina CR, Rook MB, Wilde AA. Cardiac sodium channel and inherited arrhythmia syndromes. Cardiovasc Res 2001; 49:257-271.
10. Priori SG, Napolitano C, Grillo M. Concealed arrhythmogenic syndromes: The hidden substrate of idiopathic ventricular fibrillation? Cardiovasc Res 2001; 50:218-223.
11. Alings M, Wilde A. "Brugada" syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99: 666-673.
12. Weiss R, Barmada MM, Nguyen T, et al. Clinical and molecular heterogeneity in the Brugada syndrome. A novel gene locus on chromosome 3. Circulation 2002; 105:111.
13. Nademanee K, Veerakul G, Nimmannit S, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997; 96:2595-2600.
14. Vatta M, Dumaine R, Varghese G, et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002; 11: 337-345.
15. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block hut structurally normal hearts. Circulation 2000; 101:510-515.
16. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11:1320-1329.
17. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V(1) to V(3). Circulation 2002; 105:73-78.
18. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002; 105:1342-1347.
19. Rook MB, Alshinawi CB, Groenewegen WA, et al. Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome. Cardiovasc Res 1999; 44: 507-517.
20. Deschenes I, Baroudi G, Berthet M, et al. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc Res 2000; 46:55-65.
21. Priori SG, Napolitano C, Glordano U, et al. Brugada syndrome and sudden cardiac death in children. Lancet 2000; 355:808-809.
22. Bezzina C, Veldkamp MW, van Den Berg MP, et al. A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res 1999; 85:1206-1213.
23. Kyndt F, Probst V, Potet F, et al. Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation 2001; 104:3081-3086.
24. Wan X, Wang Q, Kirsch GE. Functional suppression of sodium channels by beta(1)-subunits as a molecular mechanism of idiopathic ventricular fibrillation. J Mol Cell Cardiol 2000; 32: 1873-1884.
25. Wang DW, Makita N, Kitabatake A, et al. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. Circ Res 2000; 87: E37-E43.
26. Balser JR. Sodium "channelopathies" and sudden death. Must you be so sensitive? Circ Res 1999; 85:872-874.
27. Baroudi G, Pouliot V, Denjoy I, et al. Novel mechanism for Brugada syndrome: Defective surface localization of an SCN5A mutant (R1432G). Circ Res 2001; 88:E78-E83.
28. Baroudi G, Acharfi S, Larouche C, et al. Expression and intracellular localization of an SCN5A double mutant R1232W/T1620M implicated in Brugada syndrome. Circ Res 2002; 90:E11-E16.
29. Viswanathan PC, Bezzina CR, George AL Jr, et al. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Circulation 2001; 104:1200-1205.
30. Gima K, Rudy Y. Ionic current basis of electrocardiographic wave-forms: A model study. Circ Res 2002; 90:889-896.
31. Antzelevitch C. The Brugada syndrome: Ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001; 12:268-272.
32. Gonzalez Rebollo G, Madrid H, Carcia A, et al. Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada Syndrome. Rev Esp Cardiol 2000; 53:755-757.
33. Madle A, Kratochvil Z, Polivkova A. [The Brugada syndrome]. Vnitr Lek 2002; 48:255-258.
34. Saura D, Garcia-Alberola A, Carrillo P, et al. Brugada-like electro-cardiographic pattern induced by fever. PACE 2002; 25:856-859.
35. Porres JM, Brugada J, Urbistondo V, et al. Fever unmasking the Brugada syndrome. PACE 2002; 25:(In press).
36. Kum L, Fung JWH, Chan WWL, et al. Brugada syndrome unmasked by febrile illness. PACE 2002; 25:(In press).
37. Antzelevitch C, Fish J. Electrical heterogeneity within the ventricular wall. Basic Res Cardiol 2001; 96:517-527.
38. Yan GX, Antzelevitch C. Cellular basis for the Brugada Syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999; 100:1660-1666.
39. Antzelevitch C. The Brugada syndrome. Diagnostic criteria and cellular mechanisms. Eur Heart J 2001; 22:356-363.